Otros idiomas Biofrontera Deutsche Boerse AG

Acciones

Diferido Deutsche Boerse AG Otros sitios de cotización 08:18:04 13/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,298 ^EUR	-12,87 %		-.--%	-.--%

24/06	Biofrontera anuncia el lanzamiento de una nueva fuente de luz roja aprobada por la FDA, la lámpara RhodoLED® XL	CI
31/05	Biofrontera AG comunica los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Biofrontera Announces the Launch of A New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp	24/06
Biofrontera AG Reports Earnings Results for the First Quarter Ended March 31, 2024	31/05
Biofrontera : Quartalsmitteilung zum 1. Quartal Q1/2024	31/05
Biofrontera : Quarterly Report 1st Quarter Q1/2024	31/05
Biofrontera : GESCHÄFTSORDNUNG FÜR DEN AUFSICHTSRAT	27/05
Biofrontera : RULES OF PROCEDURE of the Supervisory Board	27/05
Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M	15/05
Biofrontera : Subscription offer (CONVENIENCE TRANSLATION)	15/05
Biofrontera : Leonteq Securities AG - Aufhebung der Zulassung zum Handel (Sponsored Segment)	14/05
Biofrontera : Bezugsangebot	08/05
Biofrontera : Announcement of capital reduction (German only)	08/05
Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Biofrontera : Jahresfinanzbericht 2023 nach HGB	30/04
Biofrontera : Abstimmungsergebnisse	04/04
Biofrontera Files Prospectus for Potential Secondary Stock Offerings	11/03
Medicus Pharma Names COO	05/03
BIOFRONTERA AG ANNOUNCES REVISED STRATEGY	21/02
BIOFRONTERA AG, BIOFRONTERA TRANSFERS CLINICAL RESEARCH TO THE U.S.	21/02
MORNING BRIEFING - Deutschland/Europa -2-	16/02
Biofrontera AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	28/11

No hay resultados para esta búsqueda